secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001493152-25-007597
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals enters advisory consulting agreement and receives $120K from warrant exercise
--------------------------------------------------------------------------------

- Issued 200,000 restricted shares to 6330 Investment & Consulting for 12-month strategic advisory services.
- Received $120,000 aggregate exercise price for 80,000 shares from a warrant holder at $1.50 per share.
- Consultant will provide introductions for strategic partners and M&A opportunities; estimated 10 hours/week.
- Shares issued under Section 4(a)(2) exemption; no public offering or underwriting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225007597/0001493152-25-007597-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225007597/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-007597

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer